Cargando…

Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved

BACKGROUND: Invasive papillary carcinoma is a rare type of invasive ductal carcinoma. Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma. CASE PRESENTATION: We discuss t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saita, Chiaki, Goto, Risa, Aruga, Tomoyuki, Idera, Nami, Honda, Yayoi, Horiguchi, Kazumi, Miyamoto, Hiromi, Horiguchi, Shinichiro, Yamashita, Toshinari, Kuroi, Katsumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727271/ https://www.ncbi.nlm.nih.gov/pubmed/26813772 http://dx.doi.org/10.1186/s13104-016-1854-4

Ejemplares similares

Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report
por: Kuroi, Katsumasa, et al.
Publicado: (2011)

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
por: Ueno, Takayuki, et al.
Publicado: (2018)

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
por: Ueno, Takayuki, et al.
Publicado: (2019)

Tumor development in Japanese patients with Lynch syndrome
por: Saita, Chiaki, et al.
Publicado: (2018)

Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer
por: Tsurutani, Junji, et al.
Publicado: (2015)

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy
por: Ueno, Takayuki, et al.
Publicado: (2016)

Main-duct intraductal papillary mucinous adenoma of the pancreas
por: Takuma, Kensuke, et al.
Publicado: (2011)

Metastasis of breast cancer to liver through direct lymphatic drainage: a case report
por: Tokisawa, Hiromi, et al.
Publicado: (2021)

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2018)

Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma
por: Sugitani, Iwao, et al.
Publicado: (2021)

ODP538 A Case of Multiple Endocrine Neoplasia Type 2A with Malignant Paraganglioma
por: Ozawa, Atsushi, et al.
Publicado: (2022)

Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
por: Tokunaga, Eriko, et al.
Publicado: (2021)

The outcome of a multidisciplinary approach incorporating neoadjuvant chemoradiotherapy with S1 for resectable pancreatic ductal adenocarcinoma
por: Matsumura, Masaru, et al.
Publicado: (2022)

A case of pneumatosis intestinalis during neoadjuvant chemotherapy with cisplatin and 5-fluorouracil for esophageal cancer(†)
por: Kouzu, Keita, et al.
Publicado: (2017)

Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database
por: Akiyama, Toru, et al.
Publicado: (2013)

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
por: Toi, M, et al.
Publicado: (2004)

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG
por: Kuroi, Katsumasa, et al.
Publicado: (2014)

Neurocysticercosis in a Japanese woman with lung cancer who repeatedly visited endemic countries
por: Kinouchi, Tomoya, et al.
Publicado: (2021)

Risk Factors for the Development of High-risk Stigmata in Branch-duct Intraductal Papillary Mucinous Neoplasms
por: Yamazaki, Tatsuhiro, et al.
Publicado: (2021)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

An overview of the Japan Breast Cancer Research Group (JBCRG) activities
por: Ohno, Shinji, et al.
Publicado: (2013)

Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer
por: Kosaka, Yoshimasa, et al.
Publicado: (2022)

Hemosuccus Pancreaticus Due to the Rupture of a Pseudoaneurysm That Developed in an Intraductal Papillary Mucinous Neoplasm
por: Obata, Taisuke, et al.
Publicado: (2021)

Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

Genetic and immunohistochemical analyses of ciliated muconodular papillary tumors of the lung: A report of five cases
por: Kashima, Jumpei, et al.
Publicado: (2019)

Investigation of Novel c-Kit-expressing Smooth Muscle Cells in Murine Cecum
por: Iino, Satoshi, et al.
Publicado: (2020)

Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer
por: Ishibashi, Yusuke, et al.
Publicado: (2020)

The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm
por: Miyamoto, Kazuya, et al.
Publicado: (2020)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
por: Martí, Covadonga, et al.
Publicado: (2021)

Neoadjuvant Endocrine Therapy (NET) in breast cancer – COVID setting
por: Bardoli, Antonio, et al.
Publicado: (2022)

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy
por: Ferraro, Emanuela, et al.
Publicado: (2020)

Selection bias due to delayed comprehensive genomic profiling in Japan
por: Tamura, Taichi, et al.
Publicado: (2022)

Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report
por: Arai, Yuichi, et al.
Publicado: (2021)

Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Quantum potential interpretation and a third-quantized universe
por: Horiguchi, T
Publicado: (1994)

Interstitial cells of Cajal in W(sh)/W(sh) c-kit mutant mice
por: Iino, Satoshi, et al.
Publicado: (2020)

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
por: Ellis, Matthew J., et al.
Publicado: (2008)

Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jge632r5bqchtu3u5mfb0d578f